Else Nutrition Holdings Valuation
Is BABY undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of BABY when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate BABY's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate BABY's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BABY?
Other financial metrics that can be useful for relative valuation.
| What is BABY's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | CA$36.10m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 3.7x |
| Enterprise Value/EBITDA | -2.1x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does BABY's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 3.4x | ||
FRSH Fresh Factory B.C | 1.3x | n/a | CA$41.7m |
SWP Swiss Water Decaffeinated Coffee | 0.2x | n/a | CA$33.8m |
BITE Blender Bites | 3.7x | n/a | CA$12.7m |
HBFG Happy Belly Food Group | 8.3x | n/a | CA$42.1m |
BABY Else Nutrition Holdings | 3.9x | n/a | CA$36.1m |
Price-To-Sales vs Peers: BABY is expensive based on its Price-To-Sales Ratio (3.9x) compared to the peer average (3.4x).
Price to Earnings Ratio vs Industry
How does BABY's PE Ratio compare vs other companies in the CA Food Industry?
Price-To-Sales vs Industry: BABY is expensive based on its Price-To-Sales Ratio (3.9x) compared to the Canadian Food industry average (0.6x).
Price to Sales Ratio vs Fair Ratio
What is BABY's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 3.9x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate BABY's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.